AcetaZOLAMIDE

AcetaZOLAMIDE
(ah set a zole’ ah mide)
Apo-Acetazolamide (CAN), Diamox Sequels
PREGNANCY CATEGORY C
Drug Classes
Antiepileptic
Antiglaucoma drug
Carbonic anhydrase inhibitor
Diuretic
Sulfonamide (nonbacteriostatic)
Therapeutic Actions
Inhibits the enzyme carbonic anhydrase. This action decreases aqueous humor formation in the eye, IOP, and hydrogen ion secretion by renal tubule cells, and increases sodium, potassium, bicarbonate, and water excretion by the kidney, causing a diuretic effect. In epilepsy, carbonic anhydrase inhibition seems to retard abnormal, excessive discharge from CNS neurons.
Indications
  • Adjunctive treatment of chronic open-angle glaucoma, secondary glaucoma
  • Preoperative use in acute angle-closure glaucoma when delay of surgery is desired to lower IOP
  • Edema caused by heart failure, drug-induced edema
  • Centrencephalic epilepsy (absence, unlocalized seizures)
  • Prophylaxis and treatment of acute mountain sickness
  • Unlabeled uses: Malignant glaucoma, migraine prevention, familial periodic paralysis, cystine or uric acid renal calculi prevention, tardive dyskinesia
Available Forms
Tablets—125, 250 mg; ER capsules—500 mg; powder for injection—500 mg/vial
Dosages
Adults
Jul 20, 2016 | Posted by in NURSING | Comments Off on AcetaZOLAMIDE

Full access? Get Clinical Tree

Get Clinical Tree app for offline access